ARQULE Trademark

Trademark Overview

On Monday, March 28, 2016, a trademark application was filed for ARQULE with the United States Patent and Trademark Office. The USPTO has given the ARQULE trademark a serial number of 86955015. The federal status of this trademark filing is REGISTERED as of Tuesday, January 8, 2019. This trademark is owned by ArQule, Inc.. The ARQULE trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceutical preparations, namely, preparations for the treatment of neurological, metabolic and inflammation related diseases
arqule

General Information

Serial Number86955015
Word MarkARQULE
Filing DateMonday, March 28, 2016
Status700 - REGISTERED
Status DateTuesday, January 8, 2019
Registration Number5649629
Registration DateTuesday, January 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2016

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical preparations, namely, preparations for the treatment of neurological, metabolic and inflammation related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 31, 2016
Primary Code005
First Use Anywhere DateSunday, August 31, 2008
First Use In Commerce DateSunday, August 31, 2008

Trademark Owner History

Party NameArQule, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameArQule, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameArQule, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Monday, January 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 8, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 4, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 3, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 5, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 10, 2018USE AMENDMENT FILED
Monday, November 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 10, 2018TEAS STATEMENT OF USE RECEIVED
Friday, May 4, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 4, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2018SOU EXTENSION 3 GRANTED
Friday, April 6, 2018SOU EXTENSION 3 FILED
Friday, April 6, 2018SOU TEAS EXTENSION RECEIVED
Friday, October 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2017SOU EXTENSION 2 GRANTED
Wednesday, October 4, 2017SOU EXTENSION 2 FILED
Wednesday, October 4, 2017SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2017SOU EXTENSION 1 GRANTED
Tuesday, February 7, 2017SOU EXTENSION 1 FILED
Tuesday, February 7, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 11, 2016ASSIGNED TO EXAMINER
Thursday, March 31, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2016NEW APPLICATION ENTERED

Related Keywords

arqule preparations inflammation metabolic related diseases neurological treatment mark pharmaceutical namely